Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
SOUTH AFRICA – The Government of South Africa, through the African Renaissance Fund (ARF), has teamed up with the African Vaccination Acquisition Trust (AVAT) to contribute a total of 2,030,400…
Read More
USA – Johnson & Johnson has announced a share repurchase program to buy back up to US$5 billion of the company’s common stock. J&J said the repurchase program announced has…
Read More
USA – Johnson & Johnson’s Biosense Webster has launched the Octaray mapping catheter with TRUEref technology designed for mapping cardiac arrhythmias, including Atrial fibrillation (AFib). It is powered by the…
Read More
KENYA – The Ministry of Health in Kenya has entered into a strategic partnership deal with multinational healthcare company Johnson & Johnson (J&J) to facilitate access to quality mental healthcare…
Read More
USA – Mathai Mammen, M.D., Ph.D., has chosen to withdraw from his role as Executive Vice President, Pharmaceuticals, R&D, at Johnson & Johnson (J&J) to seek other opportunities outside of…
Read More
USA- Johnson & Johnson (J&J) will stop making and selling its talc-based baby powder around the world from next year. The US-based Pharmaceutical and healthcare company will now stop marketing…
Read More
KENYA – The Government of Kenya, through the National Hospital Insurance Fund (NHIF), has entered into a strategic partnership deal with pharmaceutical company Johnson & Johnson Middle East FZ LLC,…
Read More
USA – Paige has announced a collaboration with Janssen Research & Development to evaluate the potential of a hematoxylin and eosin (H&E) and artificial intelligence (AI)-based biomarker test. Developed by…
Read More
USA – Johnson & Johnson has announced the termination of its collaboration and license agreements with Bavarian Nordic to develop potential vaccines against hepatitis B and human papillomaviruses (HPV). However,…
Read More
USA – Johnson & Johnson (J&J) has sued drug distributors and a pharmacy in an attempt to halt the sale of counterfeit versions of its HIV medications, seeking at least…
Read More